65
Xuan W#, Wu X*, Zheng L, Jia H, Zhang X, Zhang X*, Cao B*. Gut microbiota-derived acetic acids promoted sepsis-induced acute respiratory distress syndrome by delaying neutrophil apoptosis through FABP4. Cell Mol Life Sci. 2024 Oct 25;81(1):438. doi: 10.1007/s00018-024-05474-y.
66
Zou X#, Chang K#, Fan G#, Zheng H#, Shen H#, Tang L#, Yang Y, Wang Y, Zhao L, Lv H, Zhou X, Shen X, Chen L, Tong X*, Cao B*. Effectiveness and safety of Sanhan Huashi granules versus nirmatrelvir–ritonavir in adult patients with COVID-19: A randomized, open-label, multicenter trial. Science Bulletin. 2024, https://doi.org/10.1016/j.scib.2024.04.040.
67
Zuo W#, He D#, Liang C#, Du S, Hua Z, Nie Q, Zhou X, Yang M, Tan H, Xu J, Yu Y, Zhan Y, Zhang Y, Gu X, Zhu W, Zhang H, Li H, Sun W, Sun M, Liu X, Liu L, Cao C, Li R, Li J, Zhang Y, Zhang Y, Guo J, Zhao L, Zhang CP, Liu H, Wang S, Xiao F, Wang Y, Wang Z*, Li H*, Cao B*. The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China. Lancet Infect Dis. 2024 Apr 22:S1473-3099(24)00171-3. doi: 10.1016/S1473-3099(24)00171-3.
68
Wang Y, Guo L, Fan G, Han Y, Zhang Q, Wang W, Ren L, Zhang H, Wang G, Zhang X, Huang T, Chen L, Huang L, Gu X, Cui D, Wang X, Zhong J, Wang Y, Li H, Huang C, Wang J, Cao B. Effect of Corticosteroids on Long-term Humoral and Memory T-Cell Responses in Follow-up Visit of Hospitalized Patients With COVID-19. Chest. 2024 Mar 1:S0012-3692(24)00282-4. doi: 10.1016/j.chest.2024.02.044.
69
Gu X, Huang L, Li X, Zhou Y, Zhang H, Wang Y, Cui D, Yu T, Wang Y*, Cao B*. Association of Monocyte Count With Lung Function and Exercise Capacity Among Hospitalized COVID-19 Survivors: A 2-Year Cohort Study. Influenza Other Respir Viruses. 2024 Mar;18(3):e13263. doi: 10.1111/irv.13263.
70
Han X, Wang H, Chen L, Wang Y, Li H, Zhou F, Xing X, Zhang C, Suo L, Wang J, Yu G, Wang G, Yao X, Yu H, Wang L, Liu M, Xue C, Liu B, Zhu X, Li Y, Xiao Y, Cui X, Li L, Liu X*, Cao B*. Impact of inhaled corticosteroid use on elderly chronic pulmonary disease patients with community acquired pneumonia. Chin Med J (Engl). 2024 Jan 20;137(2):241-243. doi: 10.1097/CM9.0000000000002936.
71
Wang Y#, Guo L#, Cui D#, Zhang H#, Zhang Q, Ren L, Wang G, Zhang X, Huang T, Chen L, Huang L, Wang X, Zhong J, Wang Y, Li H, Wang J*, Cao B*. Immune Responses in Discharged COVID-19 Patients With and Without Long COVID Symptoms. Open Forum Infect Dis. 2024 Apr 1;11(4):ofae137. doi: 10.1093/ofid/ofae137.
72
Wang Y, Cao B. The insights from SARS-CoV-2 antibody treatment for future emerging infectious diseases. Lancet Infect Dis. 2024 Jan;24(1):2-3. doi: 10.1016/S1473-3099(23)00454-1.
73
Wang Y#, Kong Q#, Zhang Q, Ma T, An Y, Zhou YJ, Zhang X*, Cao B*. BPI23-Fcγ alleviates lethal multi-drug-resistant Acinetobacter baumannii infection by enhancing bactericidal activity and orchestrating neutrophil function. Int J Antimicrob Agents. 2024 Jan;63(1):107002. doi: 10.1016/j.ijantimicag.2023.107002.
74
Zhang H#, Huang C#, Gu X#, Wang Y#, Li X, Liu M, Wang Q, Xu J, Wang Y, Dai H, Zhang D*, Cao B*. 3-year outcomes of discharged survivors of COVID-19 following the SARS-CoV-2 omicron (B.1.1.529) wave in 2022 in China: a longitudinal cohort study. Lancet Respir Med. 2024 Jan;12(1):55-66. doi: 10.1016/S2213-2600(23)00387-9.
75
Cao B#*, Wang Y#, Lu H#, Huang C#, Yang Y#, Shang L, Chen Z, Jiang R, Liu Y, Lin L, Peng P, Wang F, Gong F, Hu H, Cheng C, Yao X, Ye X, Zhou H, Shen Y, Liu C, Wang C, Yi Z, Hu B, Xu J, Gu X, Shen J, Xu Y, Zhang L, Fan J, Tang R*, Wang C*. Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. N Engl J Med. 2024 Jan 18;390(3):230-241. doi: 10.1056/NEJMoa2301425. PMID: 38231624.
76
Zhao J#, Zhuo X#, Pu D, Fan G, Lu B*, and Cao B*. Comparison of influenza‐ and COVID‐19‐associated pulmonary aspergillosis in China. European Journal of Clinical Microbiology & Infectious Diseases. 2024 doi: 10.1007/s10096-024-04772-4
77
Fan G#, Zhou Y#, Zhou F, Yu Z, Gu X, Zhang X, Liu Z, Zhou M*, Cao B*. The mortality and years of life lost for community-acquired pneumonia before and during COVID-19 pandemic in China. Lancet Reg Health West Pac. 2023 doi: 10.1016/j.lanwpc.2023.100968.
78
Zhao J#, Pu D#, Li Z, Liu X, Zhang Y, Wu Y, Zhang F, Li C, Zhuo X, Lu B, Cao B*. In vitro activity of cefiderocol, a siderophore cephalosporin, against carbapenem-resistant hypervirulent Klebsiella pneumoniae in China. Antimicrob Agents Chemother. 2023 doi: 10.1128/aac.00735-23.
79
Gu X#, Wang S#, Zhang W#, Li C#, Guo L#, Wang Z, Li H, Zhang H, Zhou Y, Liang W, Li H, Liu Y, Wang Y, Huang L, Dong T, Zhang D*, Wong CCL*, Cao B*. Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. EBioMedicine. 2023 doi: 10.1016/j.ebiom.2023.104851.
80
Pu D, Zhao J, Chang K, Zhuo X, Cao B*. "Superbugs" with hypervirulence and carbapenem resistance in Klebsiella pneumoniae: the rise of such emerging nosocomial pathogens in China. Sci Bull (Beijing). 2023 doi: 10.1016/j.scib.2023.09.040.
